

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.39459543 |
| 2 | barbed-end actin filament capping (GO:0051016) | 4.19896503 |
| 3 | protein maturation by protein folding (GO:0022417) | 4.10046590 |
| 4 | membrane raft organization (GO:0031579) | 3.86123236 |
| 5 | apoptotic cell clearance (GO:0043277) | 3.73876709 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.56056752 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46418034 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.46418034 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46418034 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46418034 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46418034 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.46418034 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36571396 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36571396 |
| 15 | regulation of early endosome to late endosome transport (GO:2000641) | 3.29968941 |
| 16 | basement membrane organization (GO:0071711) | 3.26010614 |
| 17 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22039099 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.18995030 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 3.12950540 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12849908 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 3.08725242 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07183320 |
| 23 | regulation of metalloenzyme activity (GO:0048552) | 3.04144368 |
| 24 | endodermal cell differentiation (GO:0035987) | 3.03059242 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.01292170 |
| 26 | regulation of cholesterol storage (GO:0010885) | 3.00169339 |
| 27 | glycosphingolipid catabolic process (GO:0046479) | 2.99070803 |
| 28 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.97138768 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 2.96108322 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 2.96108322 |
| 31 | wound healing, spreading of epidermal cells (GO:0035313) | 2.93510109 |
| 32 | keratan sulfate catabolic process (GO:0042340) | 2.89772072 |
| 33 | skin morphogenesis (GO:0043589) | 2.83971109 |
| 34 | pentose-phosphate shunt (GO:0006098) | 2.83265359 |
| 35 | protein hydroxylation (GO:0018126) | 2.82357495 |
| 36 | response to laminar fluid shear stress (GO:0034616) | 2.82084074 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 2.80941296 |
| 38 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.80733403 |
| 39 | regulation of superoxide anion generation (GO:0032928) | 2.80396721 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 2.78240885 |
| 41 | pinocytosis (GO:0006907) | 2.76541287 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73085479 |
| 43 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72320403 |
| 44 | stress fiber assembly (GO:0043149) | 2.68888059 |
| 45 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.68078986 |
| 46 | cortical actin cytoskeleton organization (GO:0030866) | 2.66432030 |
| 47 | collagen fibril organization (GO:0030199) | 2.61882337 |
| 48 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.61828811 |
| 49 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61795016 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61692667 |
| 51 | T cell apoptotic process (GO:0070231) | 2.61096446 |
| 52 | glycolipid catabolic process (GO:0019377) | 2.60744368 |
| 53 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.60732843 |
| 54 | response to thyroid hormone (GO:0097066) | 2.60305260 |
| 55 | regulation of interferon-alpha production (GO:0032647) | 2.59617984 |
| 56 | positive regulation of receptor recycling (GO:0001921) | 2.59246653 |
| 57 | maternal placenta development (GO:0001893) | 2.56778973 |
| 58 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.54195059 |
| 59 | type B pancreatic cell proliferation (GO:0044342) | 2.54074343 |
| 60 | hemidesmosome assembly (GO:0031581) | 2.53757116 |
| 61 | NADPH regeneration (GO:0006740) | 2.53709069 |
| 62 | membrane protein ectodomain proteolysis (GO:0006509) | 2.53575452 |
| 63 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.50923184 |
| 64 | chondrocyte proliferation (GO:0035988) | 2.50840707 |
| 65 | glucose catabolic process (GO:0006007) | 2.49251688 |
| 66 | germ cell migration (GO:0008354) | 2.49123237 |
| 67 | cellular copper ion homeostasis (GO:0006878) | 2.49006701 |
| 68 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.46555111 |
| 69 | glucose 6-phosphate metabolic process (GO:0051156) | 2.46296328 |
| 70 | response to interferon-alpha (GO:0035455) | 2.45021025 |
| 71 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45019434 |
| 72 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.44505486 |
| 73 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.43968219 |
| 74 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43526618 |
| 75 | hyaluronan catabolic process (GO:0030214) | 2.43222539 |
| 76 | regulation of translational termination (GO:0006449) | 2.42815036 |
| 77 | negative regulation of fatty acid transport (GO:2000192) | 2.41683243 |
| 78 | response to peptidoglycan (GO:0032494) | 2.41272544 |
| 79 | regulation of nuclease activity (GO:0032069) | 2.41261913 |
| 80 | regulation of protein heterodimerization activity (GO:0043497) | 2.41239688 |
| 81 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.41239138 |
| 82 | phagocytosis, recognition (GO:0006910) | 2.40518437 |
| 83 | COPII vesicle coating (GO:0048208) | 2.40348878 |
| 84 | pyrimidine nucleoside salvage (GO:0043097) | 2.40289168 |
| 85 | pyrimidine-containing compound salvage (GO:0008655) | 2.40289168 |
| 86 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.40283751 |
| 87 | respiratory burst (GO:0045730) | 2.39979558 |
| 88 | negative regulation of phagocytosis (GO:0050765) | 2.39783369 |
| 89 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.39116736 |
| 90 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.38285976 |
| 91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.38258520 |
| 92 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.38116796 |
| 93 | protein retention in ER lumen (GO:0006621) | 2.38007032 |
| 94 | protein heterotrimerization (GO:0070208) | 2.37836523 |
| 95 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.37750106 |
| 96 | amino sugar catabolic process (GO:0046348) | 2.37625268 |
| 97 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37497333 |
| 98 | B cell mediated immunity (GO:0019724) | 2.36807089 |
| 99 | extracellular fibril organization (GO:0043206) | 2.36731207 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 2.36717814 |
| 101 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.36270262 |
| 102 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.36263414 |
| 103 | protein carboxylation (GO:0018214) | 2.36034855 |
| 104 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.36034855 |
| 105 | decidualization (GO:0046697) | 2.35931546 |
| 106 | collagen metabolic process (GO:0032963) | 2.35747883 |
| 107 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.34797315 |
| 108 | regulation of integrin activation (GO:0033623) | 2.34379619 |
| 109 | membrane lipid catabolic process (GO:0046466) | 2.33806896 |
| 110 | ceramide catabolic process (GO:0046514) | 2.33756761 |
| 111 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.33728448 |
| 112 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.33411073 |
| 113 | fibril organization (GO:0097435) | 2.33117505 |
| 114 | cell migration involved in heart development (GO:0060973) | 2.32953468 |
| 115 | cellular response to unfolded protein (GO:0034620) | 2.32132658 |
| 116 | collagen catabolic process (GO:0030574) | 2.31755002 |
| 117 | cortical cytoskeleton organization (GO:0030865) | 2.31582559 |
| 118 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.31507109 |
| 119 | regulation of macrophage cytokine production (GO:0010935) | 2.31278132 |
| 120 | sphingolipid catabolic process (GO:0030149) | 2.31210695 |
| 121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.30891206 |
| 122 | negative regulation of interleukin-12 production (GO:0032695) | 2.30074934 |
| 123 | angiogenesis involved in wound healing (GO:0060055) | 2.29956311 |
| 124 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.29482954 |
| 125 | ER-nucleus signaling pathway (GO:0006984) | 2.28503854 |
| 126 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.28494532 |
| 127 | endothelial cell morphogenesis (GO:0001886) | 2.28440577 |
| 128 | natural killer cell differentiation (GO:0001779) | 2.28300601 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.28295886 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.27905262 |
| 131 | vesicle coating (GO:0006901) | 2.27616733 |
| 132 | peptidyl-asparagine modification (GO:0018196) | 2.26645270 |
| 133 | extracellular matrix disassembly (GO:0022617) | 2.26426422 |
| 134 | cell-substrate junction assembly (GO:0007044) | 2.26376730 |
| 135 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.25268032 |
| 136 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.24800227 |
| 137 | detection of molecule of bacterial origin (GO:0032490) | 2.24616162 |
| 138 | negative regulation of protein autophosphorylation (GO:0031953) | 2.24405693 |
| 139 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.23965154 |
| 140 | myeloid cell homeostasis (GO:0002262) | 2.23484292 |
| 141 | peptidyl-proline hydroxylation (GO:0019511) | 2.23290428 |
| 142 | positive regulation of nuclease activity (GO:0032075) | 2.23286252 |
| 143 | DNA unwinding involved in DNA replication (GO:0006268) | 2.22825885 |
| 144 | regulation of translational fidelity (GO:0006450) | 2.22545585 |
| 145 | vagina development (GO:0060068) | 2.22079021 |
| 146 | wound healing, spreading of cells (GO:0044319) | 2.22000966 |
| 147 | platelet aggregation (GO:0070527) | 2.21156026 |
| 148 | macrophage differentiation (GO:0030225) | 2.21029617 |
| 149 | UV protection (GO:0009650) | 2.20644341 |
| 150 | positive regulation of blood coagulation (GO:0030194) | 2.20599851 |
| 151 | positive regulation of hemostasis (GO:1900048) | 2.20599851 |
| 152 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.20278657 |
| 153 | mannose metabolic process (GO:0006013) | 2.19871081 |
| 154 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.19790682 |
| 155 | regulation of extracellular matrix disassembly (GO:0010715) | 2.19449527 |
| 156 | oligosaccharide catabolic process (GO:0009313) | 2.19447996 |
| 157 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.19066633 |
| 158 | positive regulation of histone deacetylation (GO:0031065) | 2.19022691 |
| 159 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.17806433 |
| 160 | substrate-dependent cell migration (GO:0006929) | 2.17778969 |
| 161 | 4-hydroxyproline metabolic process (GO:0019471) | 2.17588847 |
| 162 | heterochromatin organization (GO:0070828) | 2.17221079 |
| 163 | lymphocyte apoptotic process (GO:0070227) | 2.16239931 |
| 164 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.15713392 |
| 165 | regulation of B cell differentiation (GO:0045577) | 2.15540308 |
| 166 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.14628030 |
| 167 | apoptotic process involved in morphogenesis (GO:0060561) | 2.14579742 |
| 168 | response to fluid shear stress (GO:0034405) | 2.14041877 |
| 169 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.12095350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.26990940 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.74446891 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.21300756 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.07513972 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.59232895 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52673912 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44517511 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32955035 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.31107910 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26996134 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.26694640 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21457475 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12601298 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10915685 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.06316288 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05865427 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05050734 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00009290 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99874071 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97852796 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97530359 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.96516131 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96444314 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94973843 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93844497 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.90266789 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80408446 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79889047 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78769753 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72287834 |
| 31 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.68194760 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67690578 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64823843 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64028352 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62129878 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61189216 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58013254 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.57278113 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.56204254 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54308258 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54155957 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50443598 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49732168 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49098761 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48338436 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47233115 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46763286 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45459793 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45312337 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45205334 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42624854 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41884653 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41811531 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41694986 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41239541 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40629271 |
| 57 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40077456 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.39746585 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39516607 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39155123 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36626166 |
| 62 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36170493 |
| 63 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.35531627 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35007228 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.34958361 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34662269 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33191452 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31627084 |
| 69 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31048204 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.30379595 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30190484 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30080806 |
| 73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30034515 |
| 74 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29581168 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26917489 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26898472 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26141148 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25273711 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25079875 |
| 80 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.23805013 |
| 81 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23772615 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23416067 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.22924475 |
| 84 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22901412 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21343076 |
| 86 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21096405 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20981361 |
| 88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20186641 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18402392 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17944164 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.17155303 |
| 92 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16887414 |
| 93 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15349726 |
| 94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13204272 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10027990 |
| 96 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09851144 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09817548 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08849096 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08708308 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07127095 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06682353 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06585731 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06003985 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05205439 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04554123 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04437320 |
| 107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03792888 |
| 108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03364238 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02971703 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02967280 |
| 111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02435089 |
| 112 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02227277 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01330264 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00893136 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00232328 |
| 116 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00032550 |
| 117 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99802957 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99387786 |
| 119 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99315174 |
| 120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99250649 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98959333 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98815507 |
| 123 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98685045 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98289033 |
| 125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98001467 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97727594 |
| 127 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97390432 |
| 128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97261252 |
| 129 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.97136536 |
| 130 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97129005 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97129005 |
| 132 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97039819 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96457179 |
| 134 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96277433 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94634647 |
| 136 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94338831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.36953467 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.51959087 |
| 3 | MP0003950_abnormal_plasma_membrane | 2.82720740 |
| 4 | MP0006054_spinal_hemorrhage | 2.66521839 |
| 5 | MP0003303_peritoneal_inflammation | 2.32573990 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.31975236 |
| 7 | MP0003436_decreased_susceptibility_to | 2.29492511 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.28904877 |
| 9 | MP0005275_abnormal_skin_tensile | 2.23550818 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.08712761 |
| 11 | MP0003279_aneurysm | 1.98039866 |
| 12 | MP0008260_abnormal_autophagy | 1.93452578 |
| 13 | MP0005503_abnormal_tendon_morphology | 1.90727534 |
| 14 | MP0004272_abnormal_basement_membrane | 1.85608310 |
| 15 | MP0005058_abnormal_lysosome_morphology | 1.82864369 |
| 16 | MP0003300_gastrointestinal_ulcer | 1.82292569 |
| 17 | MP0005451_abnormal_body_composition | 1.75517013 |
| 18 | MP0005076_abnormal_cell_differentiation | 1.75112040 |
| 19 | MP0001958_emphysema | 1.73644148 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.71120583 |
| 21 | MP0009840_abnormal_foam_cell | 1.65542034 |
| 22 | MP0005023_abnormal_wound_healing | 1.64118227 |
| 23 | MP0002419_abnormal_innate_immunity | 1.63838661 |
| 24 | MP0000685_abnormal_immune_system | 1.63417331 |
| 25 | MP0009278_abnormal_bone_marrow | 1.59274462 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.55842937 |
| 27 | MP0010307_abnormal_tumor_latency | 1.54559030 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.54461449 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.44432691 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.43051609 |
| 31 | MP0009785_altered_susceptibility_to | 1.42159220 |
| 32 | MP0006082_CNS_inflammation | 1.37502165 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.36894193 |
| 34 | MP0003448_altered_tumor_morphology | 1.35184589 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.34931213 |
| 36 | MP0005025_abnormal_response_to | 1.33714931 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.33545342 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.33545342 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.32941897 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.32436594 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.31548242 |
| 42 | MP0002933_joint_inflammation | 1.31380104 |
| 43 | MP0005165_increased_susceptibility_to | 1.31231649 |
| 44 | MP0000858_altered_metastatic_potential | 1.30659925 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.30439219 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.29646670 |
| 47 | MP0005408_hypopigmentation | 1.29410066 |
| 48 | MP0000343_altered_response_to | 1.28033520 |
| 49 | MP0003091_abnormal_cell_migration | 1.27774627 |
| 50 | MP0005171_absent_coat_pigmentation | 1.25775070 |
| 51 | MP0001800_abnormal_humoral_immune | 1.25646879 |
| 52 | MP0005387_immune_system_phenotype | 1.22733917 |
| 53 | MP0001790_abnormal_immune_system | 1.22733917 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.20234996 |
| 55 | MP0004947_skin_inflammation | 1.19876808 |
| 56 | MP0001915_intracranial_hemorrhage | 1.18409519 |
| 57 | MP0002060_abnormal_skin_morphology | 1.18333925 |
| 58 | MP0001853_heart_inflammation | 1.17997721 |
| 59 | MP0002254_reproductive_system_inflammat | 1.17429327 |
| 60 | MP0004233_abnormal_muscle_weight | 1.17140805 |
| 61 | MP0001542_abnormal_bone_strength | 1.14055705 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.13969864 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.12508361 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.11876221 |
| 65 | MP0005390_skeleton_phenotype | 1.11769241 |
| 66 | MP0001819_abnormal_immune_cell | 1.09753937 |
| 67 | MP0002420_abnormal_adaptive_immunity | 1.09591859 |
| 68 | MP0002723_abnormal_immune_serum | 1.08902573 |
| 69 | MP0002405_respiratory_system_inflammati | 1.07029247 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.05971753 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.04875039 |
| 72 | MP0000733_abnormal_muscle_development | 1.04518805 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.03321584 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.02954006 |
| 75 | MP0002166_altered_tumor_susceptibility | 1.02175249 |
| 76 | MP0005197_abnormal_uvea_morphology | 0.98582091 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 0.97539848 |
| 78 | MP0000371_diluted_coat_color | 0.96976531 |
| 79 | MP0002896_abnormal_bone_mineralization | 0.96477749 |
| 80 | MP0000490_abnormal_crypts_of | 0.95219308 |
| 81 | MP0000749_muscle_degeneration | 0.94359547 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.93636230 |
| 83 | MP0002398_abnormal_bone_marrow | 0.93616494 |
| 84 | MP0004510_myositis | 0.93594300 |
| 85 | MP0005360_urolithiasis | 0.91556779 |
| 86 | MP0003186_abnormal_redox_activity | 0.90929801 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.90125098 |
| 88 | MP0003795_abnormal_bone_structure | 0.88997178 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.88917310 |
| 90 | MP0005621_abnormal_cell_physiology | 0.88883111 |
| 91 | MP0000716_abnormal_immune_system | 0.88690567 |
| 92 | MP0001243_abnormal_dermal_layer | 0.88499693 |
| 93 | MP0008469_abnormal_protein_level | 0.88461843 |
| 94 | MP0005508_abnormal_skeleton_morphology | 0.88314935 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.88232842 |
| 96 | MP0003724_increased_susceptibility_to | 0.88210025 |
| 97 | MP0005409_darkened_coat_color | 0.87338525 |
| 98 | MP0000604_amyloidosis | 0.86739161 |
| 99 | MP0000358_abnormal_cell_content/ | 0.86490927 |
| 100 | MP0002429_abnormal_blood_cell | 0.85470437 |
| 101 | MP0002722_abnormal_immune_system | 0.85398041 |
| 102 | MP0003828_pulmonary_edema | 0.85234627 |
| 103 | MP0002006_tumorigenesis | 0.84952089 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.84906996 |
| 105 | MP0004858_abnormal_nervous_system | 0.84300515 |
| 106 | MP0005330_cardiomyopathy | 0.84295686 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.82732370 |
| 108 | MP0001661_extended_life_span | 0.82560194 |
| 109 | MP0003075_altered_response_to | 0.82431868 |
| 110 | MP0004883_abnormal_blood_vessel | 0.81971744 |
| 111 | MP0000598_abnormal_liver_morphology | 0.81630770 |
| 112 | MP0000249_abnormal_blood_vessel | 0.81192842 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.81143284 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.81019368 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.80875983 |
| 116 | MP0001849_ear_inflammation | 0.80391565 |
| 117 | MP0008007_abnormal_cellular_replicative | 0.79296269 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.76170815 |
| 119 | MP0001730_embryonic_growth_arrest | 0.76130273 |
| 120 | MP0000609_abnormal_liver_physiology | 0.75734376 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.74791229 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.73345544 |
| 123 | MP0003252_abnormal_bile_duct | 0.72918104 |
| 124 | MP0002128_abnormal_blood_circulation | 0.72720085 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.72444532 |
| 126 | MP0001614_abnormal_blood_vessel | 0.72377870 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.72039036 |
| 128 | MP0005384_cellular_phenotype | 0.71820704 |
| 129 | MP0005166_decreased_susceptibility_to | 0.70874553 |
| 130 | MP0005193_abnormal_anterior_eye | 0.70712694 |
| 131 | MP0002086_abnormal_extraembryonic_tissu | 0.70580529 |
| 132 | MP0005164_abnormal_response_to | 0.70260237 |
| 133 | MP0009053_abnormal_anal_canal | 0.69803238 |
| 134 | MP0004957_abnormal_blastocyst_morpholog | 0.69617448 |
| 135 | MP0010094_abnormal_chromosome_stability | 0.67299295 |
| 136 | MP0003077_abnormal_cell_cycle | 0.66967317 |
| 137 | MP0000747_muscle_weakness | 0.66887519 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.66253297 |
| 139 | MP0002075_abnormal_coat/hair_pigmentati | 0.65702287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.92656972 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.13577233 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.58359378 |
| 4 | Ankle contracture (HP:0006466) | 3.48697818 |
| 5 | Cervical subluxation (HP:0003308) | 3.42901181 |
| 6 | Peritonitis (HP:0002586) | 3.16439908 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.03634589 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.96871489 |
| 9 | Recurrent abscess formation (HP:0002722) | 2.96571812 |
| 10 | Vertebral compression fractures (HP:0002953) | 2.88622245 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 2.75499057 |
| 12 | Vascular tortuosity (HP:0004948) | 2.74911765 |
| 13 | Aortic dissection (HP:0002647) | 2.74687563 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 2.73457320 |
| 15 | Cholecystitis (HP:0001082) | 2.72536307 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 2.72536307 |
| 17 | Follicular hyperkeratosis (HP:0007502) | 2.71843237 |
| 18 | Arterial tortuosity (HP:0005116) | 2.67096861 |
| 19 | Hematochezia (HP:0002573) | 2.66025818 |
| 20 | Fragile skin (HP:0001030) | 2.60685958 |
| 21 | Aortic aneurysm (HP:0004942) | 2.58842427 |
| 22 | Shallow orbits (HP:0000586) | 2.54139321 |
| 23 | Myocardial infarction (HP:0001658) | 2.52683570 |
| 24 | Loss of speech (HP:0002371) | 2.50719461 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.50624186 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.50624186 |
| 27 | Nuclear cataract (HP:0100018) | 2.43179270 |
| 28 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.41355614 |
| 29 | Metaphyseal cupping (HP:0003021) | 2.40890201 |
| 30 | Mitral valve prolapse (HP:0001634) | 2.40840469 |
| 31 | Cellulitis (HP:0100658) | 2.36545983 |
| 32 | Blue sclerae (HP:0000592) | 2.35418043 |
| 33 | Genu recurvatum (HP:0002816) | 2.35264575 |
| 34 | Dilatation of the ascending aorta (HP:0005111) | 2.32223929 |
| 35 | Ulnar bowing (HP:0003031) | 2.31893238 |
| 36 | Soft skin (HP:0000977) | 2.30492234 |
| 37 | Bladder diverticulum (HP:0000015) | 2.29086882 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.28418778 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.25782145 |
| 40 | Subacute progressive viral hepatitis (HP:0006572) | 2.25679751 |
| 41 | Radial bowing (HP:0002986) | 2.25101682 |
| 42 | Upper motor neuron abnormality (HP:0002127) | 2.23342803 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23228468 |
| 44 | Generalized amyotrophy (HP:0003700) | 2.22748661 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.21056486 |
| 46 | Spinal rigidity (HP:0003306) | 2.20185861 |
| 47 | Amyloidosis (HP:0011034) | 2.18492677 |
| 48 | Elbow flexion contracture (HP:0002987) | 2.17966261 |
| 49 | Abnormality of the acetabulum (HP:0003170) | 2.16793275 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.16073123 |
| 51 | Thrombocytosis (HP:0001894) | 2.15652268 |
| 52 | Beaking of vertebral bodies (HP:0004568) | 2.11390028 |
| 53 | Short nail (HP:0001799) | 2.10132069 |
| 54 | Broad metatarsal (HP:0001783) | 2.08976197 |
| 55 | Natal tooth (HP:0000695) | 2.08068336 |
| 56 | Abnormality of the umbilical cord (HP:0010881) | 2.08059883 |
| 57 | Spondylolisthesis (HP:0003302) | 2.07523615 |
| 58 | Abnormality of dentin (HP:0010299) | 2.06260956 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.05889502 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05889502 |
| 61 | Abnormality of the lumbar spine (HP:0100712) | 2.05131156 |
| 62 | Wormian bones (HP:0002645) | 2.04595030 |
| 63 | Aneurysm (HP:0002617) | 2.03594264 |
| 64 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.03583736 |
| 65 | Upper limb amyotrophy (HP:0009129) | 2.03130681 |
| 66 | Distal upper limb amyotrophy (HP:0007149) | 2.03130681 |
| 67 | Atrophic scars (HP:0001075) | 2.02292559 |
| 68 | Thoracic kyphosis (HP:0002942) | 2.01833351 |
| 69 | Biconcave vertebral bodies (HP:0004586) | 2.00683949 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.00589984 |
| 71 | Rough bone trabeculation (HP:0100670) | 1.99785075 |
| 72 | Coxa vara (HP:0002812) | 1.98703289 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 1.98500486 |
| 74 | Abnormality of macrophages (HP:0004311) | 1.98255697 |
| 75 | Entropion (HP:0000621) | 1.98011050 |
| 76 | Glomerulonephritis (HP:0000099) | 1.97028878 |
| 77 | Increased density of long bones (HP:0006392) | 1.96675056 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 1.96134695 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 1.95742312 |
| 80 | Flat acetabular roof (HP:0003180) | 1.95062502 |
| 81 | Distal lower limb muscle weakness (HP:0009053) | 1.94902431 |
| 82 | Bowed forearm bones (HP:0003956) | 1.93650041 |
| 83 | Bowing of the arm (HP:0006488) | 1.93650041 |
| 84 | Abnormality of the thoracic spine (HP:0100711) | 1.92132559 |
| 85 | Cupped ribs (HP:0000887) | 1.91659453 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91221234 |
| 87 | Increased connective tissue (HP:0009025) | 1.91034576 |
| 88 | Trismus (HP:0000211) | 1.90610230 |
| 89 | Hepatosplenomegaly (HP:0001433) | 1.89553806 |
| 90 | Spontaneous hematomas (HP:0007420) | 1.88906593 |
| 91 | Abnormal delivery (HP:0001787) | 1.88381214 |
| 92 | Platyspondyly (HP:0000926) | 1.87772078 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85975768 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85975768 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85975768 |
| 96 | Joint stiffness (HP:0001387) | 1.84915123 |
| 97 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.84262304 |
| 98 | Lymphangioma (HP:0100764) | 1.83933392 |
| 99 | Abnormality of the calcaneus (HP:0008364) | 1.83905696 |
| 100 | Achilles tendon contracture (HP:0001771) | 1.83674977 |
| 101 | Ectopia lentis (HP:0001083) | 1.82600335 |
| 102 | Disinhibition (HP:0000734) | 1.82238404 |
| 103 | Delayed cranial suture closure (HP:0000270) | 1.81019292 |
| 104 | Thin bony cortex (HP:0002753) | 1.80250475 |
| 105 | Myositis (HP:0100614) | 1.79697703 |
| 106 | Abnormal platelet volume (HP:0011876) | 1.79296728 |
| 107 | Epiphyseal dysplasia (HP:0002656) | 1.78920535 |
| 108 | Increased mean platelet volume (HP:0011877) | 1.77842051 |
| 109 | Gingivitis (HP:0000230) | 1.77827697 |
| 110 | Nephritis (HP:0000123) | 1.77306707 |
| 111 | Slender build (HP:0001533) | 1.76803964 |
| 112 | Absent frontal sinuses (HP:0002688) | 1.76330198 |
| 113 | Mitral stenosis (HP:0001718) | 1.75999761 |
| 114 | Nonimmune hydrops fetalis (HP:0001790) | 1.75901308 |
| 115 | Periodontitis (HP:0000704) | 1.75856461 |
| 116 | Ovoid vertebral bodies (HP:0003300) | 1.75489692 |
| 117 | Osteomyelitis (HP:0002754) | 1.75455970 |
| 118 | Hyperacusis (HP:0010780) | 1.73536982 |
| 119 | Tetraparesis (HP:0002273) | 1.72566662 |
| 120 | Abnormality of carpal bone ossification (HP:0006257) | 1.71965783 |
| 121 | Cutaneous melanoma (HP:0012056) | 1.71833420 |
| 122 | Abnormality of complement system (HP:0005339) | 1.71745767 |
| 123 | Hypokinesia (HP:0002375) | 1.71388800 |
| 124 | Wrist flexion contracture (HP:0001239) | 1.71216894 |
| 125 | Deep venous thrombosis (HP:0002625) | 1.70884216 |
| 126 | Albinism (HP:0001022) | 1.69776557 |
| 127 | Abnormal trabecular bone morphology (HP:0100671) | 1.69751542 |
| 128 | Joint laxity (HP:0001388) | 1.68624524 |
| 129 | Disproportionate tall stature (HP:0001519) | 1.68284014 |
| 130 | Pustule (HP:0200039) | 1.68147552 |
| 131 | Syringomyelia (HP:0003396) | 1.68121778 |
| 132 | Spinal cord lesions (HP:0100561) | 1.68121778 |
| 133 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.67867331 |
| 134 | Exostoses (HP:0100777) | 1.67522303 |
| 135 | Esophageal varix (HP:0002040) | 1.67481402 |
| 136 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67362816 |
| 137 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67362816 |
| 138 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67362816 |
| 139 | Axonal loss (HP:0003447) | 1.66501344 |
| 140 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.64618933 |
| 141 | Thick nail (HP:0001805) | 1.64512805 |
| 142 | Alopecia of scalp (HP:0002293) | 1.64304508 |
| 143 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.63825752 |
| 144 | Single umbilical artery (HP:0001195) | 1.63825752 |
| 145 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.63825752 |
| 146 | Broad face (HP:0000283) | 1.62343819 |
| 147 | Fatigue (HP:0012378) | 1.62233810 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.61556407 |
| 149 | Prolonged neonatal jaundice (HP:0006579) | 1.60700688 |
| 150 | White forelock (HP:0002211) | 1.60319220 |
| 151 | Abnormality of glycolysis (HP:0004366) | 1.60164043 |
| 152 | J-shaped sella turcica (HP:0002680) | 1.59835206 |
| 153 | Orthostatic hypotension (HP:0001278) | 1.59465630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.23695155 |
| 2 | ERN1 | 3.54331432 |
| 3 | PKN2 | 3.48138088 |
| 4 | MAP3K10 | 2.94802736 |
| 5 | MST1R | 2.63543912 |
| 6 | SMG1 | 2.43893355 |
| 7 | TTN | 2.42651533 |
| 8 | EEF2K | 2.35179502 |
| 9 | SIK3 | 2.30985518 |
| 10 | MAP4K1 | 2.08907813 |
| 11 | EIF2AK1 | 2.04716379 |
| 12 | RIPK1 | 2.02706545 |
| 13 | TGFBR2 | 1.98215943 |
| 14 | FLT3 | 1.97554911 |
| 15 | PAK4 | 1.88161476 |
| 16 | LIMK1 | 1.87963927 |
| 17 | LRRK2 | 1.86549139 |
| 18 | PIM2 | 1.84307004 |
| 19 | PDK2 | 1.79981654 |
| 20 | PBK | 1.79640426 |
| 21 | CDK12 | 1.75526698 |
| 22 | KIT | 1.73840614 |
| 23 | TBK1 | 1.72790001 |
| 24 | PTK6 | 1.71097049 |
| 25 | SCYL2 | 1.71039581 |
| 26 | BUB1 | 1.70699971 |
| 27 | STK10 | 1.69929548 |
| 28 | TYK2 | 1.64003596 |
| 29 | DDR2 | 1.50497035 |
| 30 | SIK1 | 1.49767113 |
| 31 | BLK | 1.48717696 |
| 32 | MAP2K3 | 1.48377896 |
| 33 | ICK | 1.46683982 |
| 34 | RPS6KA4 | 1.45254418 |
| 35 | MET | 1.42153735 |
| 36 | BMX | 1.41708843 |
| 37 | NME2 | 1.39868648 |
| 38 | TGFBR1 | 1.38929228 |
| 39 | CSF1R | 1.35192763 |
| 40 | EPHA2 | 1.34064985 |
| 41 | PDGFRA | 1.30189985 |
| 42 | NEK9 | 1.27640814 |
| 43 | JAK3 | 1.27390037 |
| 44 | NEK1 | 1.24087985 |
| 45 | MOS | 1.22035533 |
| 46 | CDK6 | 1.19866554 |
| 47 | MAP3K14 | 1.19133833 |
| 48 | ERBB4 | 1.15305610 |
| 49 | MAP3K3 | 1.14820971 |
| 50 | EIF2AK3 | 1.14110361 |
| 51 | VRK2 | 1.13174173 |
| 52 | PIM1 | 1.12090632 |
| 53 | EPHB2 | 1.11845080 |
| 54 | ZAP70 | 1.05429900 |
| 55 | CSK | 1.04289908 |
| 56 | PRPF4B | 1.03741377 |
| 57 | TRIM28 | 1.03602276 |
| 58 | CAMK1D | 1.01153404 |
| 59 | BTK | 1.00092949 |
| 60 | BRSK1 | 0.99715107 |
| 61 | CDK4 | 0.99486914 |
| 62 | FER | 0.98839662 |
| 63 | NEK2 | 0.95300422 |
| 64 | PAK2 | 0.94937296 |
| 65 | ARAF | 0.94629899 |
| 66 | MYLK | 0.94001470 |
| 67 | RPS6KB2 | 0.93023582 |
| 68 | MAP3K8 | 0.91481733 |
| 69 | RIPK4 | 0.91144035 |
| 70 | MATK | 0.90936580 |
| 71 | FGFR4 | 0.87626199 |
| 72 | STK3 | 0.87158850 |
| 73 | MAP3K11 | 0.85119532 |
| 74 | CDC42BPA | 0.84695581 |
| 75 | MARK3 | 0.83263555 |
| 76 | IKBKB | 0.82975182 |
| 77 | JAK1 | 0.82737362 |
| 78 | CLK1 | 0.82447798 |
| 79 | LMTK2 | 0.79459807 |
| 80 | EPHB1 | 0.76554760 |
| 81 | TRPM7 | 0.76147318 |
| 82 | MTOR | 0.75536867 |
| 83 | CHUK | 0.74523193 |
| 84 | HCK | 0.73983035 |
| 85 | TIE1 | 0.72529871 |
| 86 | KDR | 0.71908747 |
| 87 | LATS1 | 0.70744552 |
| 88 | LATS2 | 0.70022780 |
| 89 | TESK1 | 0.68854408 |
| 90 | MAP3K13 | 0.68354860 |
| 91 | PTK2 | 0.66827704 |
| 92 | GSK3A | 0.65651446 |
| 93 | IRAK4 | 0.65315375 |
| 94 | NTRK1 | 0.62286890 |
| 95 | MELK | 0.61752653 |
| 96 | ILK | 0.61564415 |
| 97 | MAP3K12 | 0.60891148 |
| 98 | CDK7 | 0.60041857 |
| 99 | STK4 | 0.60035052 |
| 100 | GRK6 | 0.59203740 |
| 101 | PAK1 | 0.57971926 |
| 102 | ABL2 | 0.57137739 |
| 103 | JAK2 | 0.54218573 |
| 104 | FGR | 0.53837365 |
| 105 | PRKCI | 0.53026331 |
| 106 | TAOK2 | 0.51463474 |
| 107 | PRKD2 | 0.51023836 |
| 108 | DYRK1B | 0.49967520 |
| 109 | SYK | 0.48922906 |
| 110 | EGFR | 0.48875242 |
| 111 | TEC | 0.48434884 |
| 112 | RPS6KA6 | 0.48310394 |
| 113 | PDGFRB | 0.47775947 |
| 114 | ROCK2 | 0.47687350 |
| 115 | IRAK3 | 0.47669293 |
| 116 | LYN | 0.47204793 |
| 117 | DAPK1 | 0.46824254 |
| 118 | MAP2K2 | 0.45293165 |
| 119 | ABL1 | 0.45277372 |
| 120 | MAPKAPK3 | 0.45111490 |
| 121 | WEE1 | 0.44859694 |
| 122 | PRKD3 | 0.44793445 |
| 123 | BRAF | 0.43755523 |
| 124 | ALK | 0.43290108 |
| 125 | RPS6KC1 | 0.43078610 |
| 126 | RPS6KL1 | 0.43078610 |
| 127 | FGFR3 | 0.42589434 |
| 128 | CDK8 | 0.42555648 |
| 129 | KSR1 | 0.42109732 |
| 130 | TSSK6 | 0.40300148 |
| 131 | PDPK1 | 0.40054023 |
| 132 | PRKG2 | 0.40013669 |
| 133 | MAPK11 | 0.39979703 |
| 134 | LCK | 0.39854745 |
| 135 | PASK | 0.39722723 |
| 136 | IKBKE | 0.39560105 |
| 137 | MAPKAPK2 | 0.38729265 |
| 138 | DAPK3 | 0.38715961 |
| 139 | TAOK3 | 0.38699527 |
| 140 | ROCK1 | 0.38374923 |
| 141 | ACVR1B | 0.38066545 |
| 142 | MAP2K1 | 0.37818507 |
| 143 | BRSK2 | 0.37523443 |
| 144 | ERBB3 | 0.37359081 |
| 145 | RAF1 | 0.36112932 |
| 146 | TESK2 | 0.34194290 |
| 147 | RPS6KA2 | 0.33896426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.33588441 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.10393698 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.10264668 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07438320 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.87453215 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 1.84495315 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79854169 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79031589 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 1.71988358 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71485567 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.70326838 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.70265861 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63844159 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58597388 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58016747 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.57288834 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56880182 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53980824 |
| 19 | Amoebiasis_Homo sapiens_hsa05146 | 1.52690543 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49370949 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.48336221 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.47216570 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46554964 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.45852887 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.43094214 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.41273026 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40487848 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.35339132 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33231669 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31181124 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.29375979 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.28330564 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27777134 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.27651487 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22591412 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.21106847 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17238830 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15857117 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13395146 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11585916 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.10661072 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.09096007 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08003194 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07798896 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07756833 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.06758921 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03919733 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03269028 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.03013541 |
| 50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02329397 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99646034 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99366859 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98688195 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98069523 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.97393435 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96513904 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94921707 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.93973642 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93957884 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93576511 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93556626 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90863116 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.90647424 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.89766356 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.89463478 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88432261 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88152573 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87613505 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86887542 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86214772 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85715606 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85418118 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84960787 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83246208 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83182553 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82267297 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81698875 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81375575 |
| 79 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78978408 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78807002 |
| 81 | Base excision repair_Homo sapiens_hsa03410 | 0.78467723 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78068529 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77356976 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77267389 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.76288887 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74908177 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74700027 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73937168 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70840872 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70584239 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.69769556 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67742924 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67310241 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66512599 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66033705 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65463369 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64783745 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64773093 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63980977 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62924163 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62677782 |
| 102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62215943 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62145875 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61688355 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60876960 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.60331786 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60284560 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58501967 |
| 109 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58489178 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58250266 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57957797 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57409796 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.56256256 |
| 114 | * Lysine degradation_Homo sapiens_hsa00310 | 0.56001064 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55702150 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55492771 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55323979 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52990741 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52986759 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52691796 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51699406 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.48242164 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47445290 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | 0.46675283 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.42958157 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40967897 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40147326 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.39489476 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38288988 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.37943771 |
| 131 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36796953 |

